What Influences Patient Outcome in Obstructive Airway Disease?
Completed
- Conditions
- COPD
- Registration Number
- NCT01221480
- Lead Sponsor
- University of Dundee
- Brief Summary
The aim of this observational study is to utilise the established record linkage data available in Tayside to investigate hospital admissions, exacerbations and mortality in COPD.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 5977
Inclusion Criteria
- Data collected through TARDIS database
Exclusion Criteria
- History of asthma or malignancy. Less than 50 years of age
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method All-cause Mortality 3000 days All-cause Mortality
- Secondary Outcome Measures
Name Time Method Hospital Admissions 3000 days Hospital Admissions
COPD exacerbations 3000 days COPD exacerbations
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms explain beta-blockers' efficacy in COPD exacerbation reduction?
How do beta-blockers compare with standard inhaled therapies in COPD mortality outcomes?
Which biomarkers correlate with beta-blocker response in COPD patients per NCT01221480 data?
What adverse event profiles are observed when beta-blockers are added to COPD maintenance therapy?
Are there combination therapies involving beta-blockers that enhance COPD treatment outcomes?